Atlas Trials

Single Ascending Dose Study (SAD) iv Formulation

Clinical trial NCT00688831 · COMPLETED

Trial details

NCT number
NCT00688831
Sponsor
AstraZeneca
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2008-01-01
Primary completion
2008-05-01
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.